Abbott's Libre Assist will help individuals with diabetes better understand how their food choices may affect their glucose ...

Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

Semaglutide, the active ingredient in medications like Ozempic and Wegovy, shows promise as a treatment for alcohol addiction ...

In honor of Diabetes Awareness Month, Episcopal Health Services (EHS) hosted a special hybrid community event on Wednesday, ...

Metformin for weight loss was prescribed to Jelly Roll by nurse practitioner Danese Raxroad to reduce triglycerides and improve insulin signaling during his transformation ...

Dietary support plays an instrumental role in managing health issues, from metabolic, cardiovascular to reproductive. Find ...

The company said the regulator accepted a priority review to potentially expand the current age range for its Tzield type-1 diabetes drug to include children as young as one year old.

Investing.com -- Sanofi announced Monday that the U.S. Food and Drug Administration has accepted a priority review for its Tzield type-1 diabetes drug, potentially expanding its use to children as ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk ...

Novo Nordisk is the first manufacturer to market its drug Wegovy in pill form in the U.S., though Eli Lilly expects approval ...

Abbott has launched Libre Assist, a feature within the Libre app designed to help people living with diabetes better understand how the foods they eat affect their glucose levels.

New regulations come into force Monday in Britain banning daytime TV and online adverts for so-called junk foods, in what the ...